J Gen Virol Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 46 (1980), 311-324; DOI 10.1099/0022-1317-46-2-311
© 1980 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bendinelli, M.
Right arrow Articles by Revoltella, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bendinelli, M.
Right arrow Articles by Revoltella, R.
Agricola
Right arrow Articles by Bendinelli, M.
Right arrow Articles by Revoltella, R.

Immunoglobulins in Human Serum Reactive with Murine Friend Leukaemia Virus

Mauro Bendinelli, Antonio Toniolo, Donatella Matteucci, Franco Celeste1 and Roberto Revoltella1,*

Institute of Microbiology, University of Pisa, Via S. Zeno, 39 Pisa
1 Laboratory of Cell Biology, Tumour Immunobiology Unit, C.N.R., Via Romagnosi 18/A, Rome, Italy

Fresh human sera neutralize Friend leukaemia virus (FLV). The activity is abolished by heating (56 °C for 30 min), hydrazine and EDTA treatment, suggesting the involvement of complement. Human sera also contain antibody which specifically reacts with FLV. Following incubation with human whole serum, IgG and F(ab')2 fragments, FLV acquire the ability to bind anti-human Ig sera, as shown in neutralization and radioimmunoprecipitation assays. The same is true for FLV-infected cells but not for uninfected control cells, as assessed by immunofluorescence. The binding of antibody to FLV-infected cells is prevented by pre-treating the cells with antisera to FLV and FLV-gp71, and is competed by FLV, FLV-gp71 and, to a lesser extent, by FLV-p12 and p30.

* To whom reprint requests should be addressed.

Received 17 April 1979; accepted 3 September 1979.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1980 by the Society for General Microbiology.